MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The regulatory variant c.–253C>T of the DNAJC13 gene as a causal factor for Parkinson’s disease in a patient with early-onset

J. Hoenicka, A. Pascual, P. García-Ruíz, X. Castro-Martínez, R. Repossi, O. de Fabregues, L. Vela-Desojo, M. Mata, I. Torres, JC. Martinez-Castrillo, F. Palau, G. Fernandez (Mexico City, Mexico)

Meeting: 2025 International Congress

Keywords: Parkinson’s, Parkinsonism

Category: Parkinson's Disease: Genetics

Objective: This work aims to investigate the role of regulatory regions in Parkinson’s disease (PD) genes, which may help explain part of the missing heritability.

Background: Genetic diagnosis of  PD focuses primarily on coding genome regions, with limited results. While special emphasis has been placed on coding regions due to their important impact on protein function, many non-coding regions linked to this disease have emerged in GWAS (1,2). In addition, some associations of variants in the 3’UTR region of the SNCA gene have been described in PD (3). In this work, we explored 77 regulatory regions of 39 genes associated with PD in a series of 103 patients with early-onset Parkinson’s disease (EOPD).

Method: We used a custom panel that included regulatory regions chosen from ENCODE data. The first-level filtering criteria were MAF < 0.01 and a CADD score > 10. In silico analysis was conducted using JASPAR. The effect of variants on gene expression was examined through luciferase assays of genomic fragments containing the variants in cell lines. Functional genomics was performed on the patient’s fibroblasts.

Results: The non-coding variants prioritized after filtering the panel results were: PRKN:c.171+415T>C (intron 2/11), SNCA:c.-26+62G>T (intron 1/5), SNCA:c.*77C>A (3’-UTR), VPS35:c.*422C>A (3’-UTR), and DNAJC13:c.-253C>T (5’-UTR). Among them, the c.-253C>T variant of DNAJC13 (NM_015268.3) stood out with a CADD score of 18.22 and is classified as of uncertain significance (VUS, ACMG). In silico and functional studies showed that this variant affects gene regulation. The c.-253C>T variant is predicted to bind three new transcription factors compared to wild-type. WES analysis of the patient carrying this variant revealed no additional findings. Functional studies of promoter activity in cell lines indicated that c.-253C>T significantly impacted expression (Figure). In contrast, the patient’s fibroblasts exhibited a significant decrease in DNAJC13 expression under both normal (p=0.00066) and starvation conditions (p=0.0224). Furthermore, autophagy marker studies revealed defects in basal autophagy in the patient’s fibroblasts.

Conclusion: The association between DNAJC13 and PD has been controversial recently. However, the non-coding variant c.-253C>T in this gene represents a promising discovery, highlighting the significance of gene regulatory regions in the vulnerability of PD.

Figure

Figure

References: 1. DOI: 10.1016/S1474-4422(19)30320-5
2. DOI: 10.1093/brain/awac022
3. https://doi.org/10.1038/ncomms2032

To cite this abstract in AMA style:

J. Hoenicka, A. Pascual, P. García-Ruíz, X. Castro-Martínez, R. Repossi, O. de Fabregues, L. Vela-Desojo, M. Mata, I. Torres, JC. Martinez-Castrillo, F. Palau, G. Fernandez. The regulatory variant c.–253C>T of the DNAJC13 gene as a causal factor for Parkinson’s disease in a patient with early-onset [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/the-regulatory-variant-c-253ct-of-the-dnajc13-gene-as-a-causal-factor-for-parkinsons-disease-in-a-patient-with-early-onset/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-regulatory-variant-c-253ct-of-the-dnajc13-gene-as-a-causal-factor-for-parkinsons-disease-in-a-patient-with-early-onset/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley